BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] External costs Research And Development, External Costs Research And Development, External Costs Statistical Measurement [Domain] Statistical Measurement [Domain] Working capital Working Capital Working capital. Schedule of Marketable Securities Debt Securities, Available-for-Sale [Table Text Block] Payment of upfront fees Collaborative Arrangement, Payment Of Upfront Fees Collaborative Arrangement, Payment Of Upfront Fees Award Timing Predetermined Award Timing Predetermined [Flag] Entity File Number Entity File Number Additional Paid-in Capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] Research and development service agreements, noncurrent Research And Development Service Agreements, Noncurrent Research And Development Service Agreements, Noncurrent Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Accounts payable Increase (Decrease) in Accounts Payable Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Net loss per common share, basic (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Other, current Other Assets, Miscellaneous, Current Liabilities included in: Liabilities, Fair Value Disclosure [Abstract] Common stock, shares reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Derek Meisner [Member] Derek Meisner Sales and Royalties Sales And Royalties [Member] Sales And Royalties Award Date [Axis] Award Date [Axis] Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Debt, short-term Less: debt, short-term Short-Term Debt Other, noncurrent Other Assets, Miscellaneous, Noncurrent Adjustment to Compensation, Amount Adjustment to Compensation Amount Discount Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Other long-term assets Increase (Decrease) in Other Operating Assets Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Shares issuable upon exercise of stock options Stock Options Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Research and development Research And Development Liability Research And Development Liability Antidilutive Securities [Axis] Antidilutive Securities [Axis] Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Total stock-based compensation Share-Based Payment Arrangement, Expense Other Other Sundry Liabilities Common stock, shares authorized (in shares) Common Stock, Shares Authorized Upfront payment received Collaborative Arrangement, Rights And Obligations, Maximum Option Payment Collaborative Arrangement, Rights And Obligations, Maximum Option Payment Noncash interest expense Other Noncash Expense, Interest Other Noncash Expense, Interest Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax [Abstract] Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Private placement issuance of common stock, net of offering costs (in shares) Stock Issued During Period, Shares, New Issues Current assets Assets, Current [Abstract] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total liabilities and stockholders’ equity Liabilities and Equity JCR Pharmaceuticals JCR Pharmaceuticals [Member] JCR Pharmaceuticals Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Stock Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Concentrations of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Sale of stock, commission rate to sales agents (as percent) Sale of Stock, Commission Rate to Sales Agents Sale of Stock, Commission Rate to Sales Agents Cover [Abstract] Cover [Abstract] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Maximum Maximum [Member] General and administrative General and Administrative Expense [Member] Accounting Policies [Abstract] Accounting Policies [Abstract] Fair Value Debt Securities, Available-for-Sale, Unrealized Loss Position Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Debt Instrument [Line Items] Debt Instrument [Line Items] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Total Debt, Long-Term and Short-Term, Combined Amount Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Operating lease liability Operating Lease, Liability Greater than 12 Months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer [Abstract] Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Government and agency - U.S. Government and agency - U.S. US Government Agencies Debt Securities [Member] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Derek Meisner Plan 2 [Member] Derek Meisner Plan 2 Available-for-sale securities, short-term Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax, Current Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax, Current Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Matthew Zuga [Member] Matthew Zuga Entity Shell Company Entity Shell Company Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Expired (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Name Measure Name Internally managed costs Research And Development, Internally-Managed Costs Research And Development, Internally-Managed Costs Other receivables Other Receivables Schedule of Share-Based Compensation Expense Related to Stock Options Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Secured Debt Secured Debt [Member] Payment obligation, term (in years) Collaborative Arrangement, Term Collaborative Arrangement, Term Schedule of the Fair Value using Level 3 Significant Unobservable Inputs Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Class of Stock [Line Items] Class of Stock [Line Items] Realized gain on marketable securities Marketable Security, Realized Gain (Loss) Document Fiscal Period Focus Document Fiscal Period Focus Shares of common stock outstanding maximum (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares of Common Stock Outstanding Maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Shares of Common Stock Outstanding Maximum Award Timing Method Award Timing Method [Text Block] Award Type [Axis] Award Type [Axis] Debt, long-term Total debt, long-term Long-Term Debt Total assets Assets Schedule of Nonvested Restricted Stock Units Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Trading Symbol Trading Symbol Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Cash and Cash Equivalents and Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Total Accrued Liabilities and Other Liabilities Entity Address, City or Town Entity Address, City or Town Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] License Agreements Lonza License Agreement [Member] Lonza License Agreement Award Date, Three Award Date, Three [Member] Award Date, Three Marketable Securities [Line Items] Marketable Securities [Line Items] Other segment expenses Segment Reporting, Other Segment Item, Amount Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Unvested RSUs RSUs Restricted Stock Units (RSUs) [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Assets included in: Assets, Fair Value Disclosure [Abstract] Award Date, Two Award Date, Two [Member] Award Date, Two Schedule of Accrued Expenses and Other Current Liabilities Disclosure Of Accrued Expenses And Other Current Liabilities [Table Text Block] Disclosure of accrued expenses and other current liabilities [Table text block]. Entity Emerging Growth Company Entity Emerging Growth Company Shares issuable upon exercise of warrant Common Stock Warrant Warrant [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Stock options outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax [Abstract] Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Direct fees Debt Issuance Costs, Net Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Final payment fee Debt Instrument, Fee Amount Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding SUPPLEMENTAL FINANCIAL INFORMATION Supplemental Financial Information [Text Block] Supplemental financial information [Text block]. Plan Name [Axis] Plan Name [Axis] PEO PEO [Member] Interest income Investment Income, Interest Shares issued in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Stock options exercised for cash Stock Issued During Period, Value, Stock Options Exercised Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Common stock, number of voting rights Common Stock, Number Of Voting Rights Common Stock, Number Of Voting Rights Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Accumulated Deficit Retained Earnings [Member] Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Effective interest rate during period Debt Instrument, Interest Rate, Effective Percentage Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash and cash equivalents and restricted cash at the beginning of the period Cash and cash equivalents and restricted cash at the end of the period Total cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Fair Value Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Variable interest rate (as percent) Debt Instrument, Basis Spread on Variable Rate Purchases of marketable securities Payments to Acquire Marketable Securities Sale of Stock [Domain] Sale of Stock [Domain] Cliff period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Cliff Period Share-Based Compensation Arrangement by Share-Based Payment Award, Cliff Period Marketable securities Investments, Fair Value Disclosure Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Product and Service [Domain] Product and Service [Domain] Covenant, proceeds from issuance of debt required (at least) Debt Instrument, Covenant, Proceeds From Issuance Of Debt Required Debt Instrument, Covenant, Proceeds From Issuance Of Debt Required Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Debt Securities, Available-for-Sale [Abstract] Available-for-sale securities, short-term Debt Securities, Available-for-Sale, Amortized Cost, Current Interest expense based on the coupon interest rate of the outstanding debt Interest Expense, Debt, Excluding Amortization Offering costs included in accrued expenses and other current liabilities Noncash Offering Costs Included In Accrued Liabilities, Current Noncash Offering Costs Included In Accrued Liabilities, Current Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Total fair value Liabilities, Fair Value Disclosure Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Amortization of right-of-use asset Operating Lease, Right-of-Use Asset, Periodic Reduction Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Proceeds from exercise of stock options Proceeds from Stock Options Exercised Proceeds from private placement, net of offering costs Proceeds from Issuance of Private Placement City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Accrued expenses and other current liabilities Accrued Liabilities, Current Unvested beginning balance (in shares) Unvested ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] General and administrative General and Administrative Expense Option, cost not yet recognized, amount Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Debt securities, available-for-sale, current, term (in years) Debt Securities, Available-for-Sale, Current, Term Debt Securities, Available-for-Sale, Current, Term Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Schedule of Assumptions Used for Valuation of Fair Value of Stock Options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Depreciation Depreciation Vested and exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Money market securities Money Market Funds [Member] Equity Components [Axis] Equity Components [Axis] Entity Ex Transition Period Entity Ex Transition Period Future milestone payment received Collaborative Arrangement, Future Milestone Payment Collaborative Arrangement, Future Milestone Payment DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Nature of Operations [Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Number of reportable segments Number of Reportable Segments Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Class of warrants or rights term (in years) Warrants and Rights Outstanding, Term Supplemental disclosure of cash flow information Supplemental Cash Flow Information [Abstract] Other Performance Measure, Amount Other Performance Measure, Amount Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Entity Address, State or Province Entity Address, State or Province Available-for-sale securities, short-term Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax, Current Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax, Current Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Total current liabilities Liabilities, Current Net change in cash and cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Derivative Instrument [Axis] Derivative Instrument [Axis] Individual: Individual [Axis] Vesting [Axis] Vesting [Axis] Restricted cash Restricted Cash Research and development Research and Development Expense [Member] Net cash (used in) provided by investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Schedule of Cash, Cash Equivalents and Restricted Cash Schedule of Cash, Cash Equivalents and Restricted Cash [Table Text Block] Schedule of Cash, Cash Equivalents and Restricted Cash Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Right-of-use asset Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Entity Interactive Data Current Entity Interactive Data Current Shares Of Common Stock Received Upon Exercise Of Option Awards [Member] Shares Of Common Stock Received Upon Exercise Of Option Awards Plan Name [Domain] Plan Name [Domain] Weighted average period of recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Stock options exercised for cash (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period SEGMENT REPORTING Segment Reporting Disclosure [Text Block] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Other Commitments [Line Items] Other Commitments [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Other Other Assets, Miscellaneous Purchases of property and equipment Payments to Acquire Productive Assets Other assets, long-term Other long-term assets Other Assets, Noncurrent Entity Central Index Key Entity Central Index Key PEO Name PEO Name Conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Schedule of Aggregate Principal Payments Schedule of Maturities of Long-Term Debt [Table Text Block] Sale of stock, consideration received on transaction Sale of Stock, Consideration Received on Transaction Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Research and development Research and Development Expense [Abstract] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Share-Based Payment Arrangement, Tranche One Share-Based Payment Arrangement, Tranche One [Member] Expected volatility, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum MARKETABLE SECURITIES Financial Instruments Disclosure [Text Block] Segments [Axis] Segments [Axis] Exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Class of Stock [Domain] Class of Stock [Domain] Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Non option, cost not yet recognized, amount Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Research and development service agreements, current Research And Development Service Agreements, Current Research And Development Service Agreements, Current STOCK-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Conversion, if-converted amount Debt Instrument, Convertible, If-converted Value Debt Instrument, Convertible, If-converted Value ASSETS Assets [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Vesting [Domain] Vesting [Domain] Debt Instrument, Redemption [Line Items] Debt Instrument, Redemption [Line Items] Debt Instrument [Axis] Debt Instrument [Axis] FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Stockholders’ equity Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Research and development service agreements Research And Development Service Agreements Research And Development Service Agreements Vesting percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Research and development Research and Development Expense Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Interest rate (as percent) Debt Instrument, Interest Rate, Stated Percentage Accrued expenses and other liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued clinical trial expenses Increase (Decrease) in Accrued Clinical Trial Expenses Increase (Decrease) in Accrued Clinical Trial Expenses Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Minimum required payment, outstanding debt requirement (at least) Debt Instrument, Minimum Required Payment, Outstanding Debt Requirement Debt Instrument, Minimum Required Payment, Outstanding Debt Requirement Shares Of Common Stock Received Upon Settlement Of RSU Awards [Member] Shares Of Common Stock Received Upon Settlement Of RSU Awards Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Schedule of Outstanding Debt and Interest Expense Schedule of Long-Term Debt Instruments [Table Text Block] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Vested and exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Document Quarterly Report Document Quarterly Report Fair Value Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Total fair value Assets, Fair Value Disclosure Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Dues and subscriptions Dues And Subscriptions Dues And Subscriptions Number of operating segments Number of Operating Segments Amortization of premiums and accretion of discounts on marketable securities, net Accretion (Amortization) of Discounts and Premiums, Investments Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Outstanding balance (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Offering costs included in accounts payable Noncash Offering Costs Included In Accounts Payable, Current Noncash Offering Costs Included In Accounts Payable, Current Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Derek Meisner Plan 1 [Member] Derek Meisner Plan 1 Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Total Prepaid Expense and Other Assets Restatement Determination Date: Restatement Determination Date [Axis] Non-PEO NEO Non-PEO NEO [Member] Ending balance, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Debt securities, available-for-sale, allowance for credit loss Debt Securities, Available-for-Sale, Allowance for Credit Loss Schedule of Prepaid Expenses and Other Current Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Less than 12 Months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months [Abstract] Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Total interest expense related to debt Interest Expense, Debt Sale of Stock [Axis] Sale of Stock [Axis] Name Trading Arrangement, Individual Name Award Type [Domain] Award Type [Domain] Embedded derivatives liability Fair value of bifurcated embedded derivatives Embedded Derivative, Fair Value of Embedded Derivative Liability Other comprehensive gain (loss) Statement of Other Comprehensive Income [Abstract] Equity Awards Adjustments Equity Awards Adjustments [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Compensation Amount Outstanding Recovery Compensation Amount Common stock and preferred stock, shares authorized (in shares) Common Stock and Preferred Stock, Shares Authorized Common Stock and Preferred Stock, Shares Authorized Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Recovery of Erroneously Awarded Compensation Disclosure [Line Items] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Unvested beginning balance (in dollars per share) Unvested ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Restricted cash Restricted Cash, Noncurrent Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Employee Stock Employee Stock [Member] Cash equivalents Cash Equivalents, at Carrying Value Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Year ended December 31, 2027 Long-Term Debt, Maturity, Year One Financial Instruments [Domain] Financial Instruments [Domain] Unrealized (loss) gain on marketable securities Unrealized (loss) gain on marketable securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Segments [Domain] Segments [Domain] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Award Date [Domain] Award Date [Domain] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Warrants (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Minimum Minimum [Member] Accumulated depreciation, property and equipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Net Loss Per Share of Common Stock Earnings Per Share, Policy [Policy Text Block] Jeffery Ives [Member] Jeffery Ives Company Selected Measure Name Company Selected Measure Name DEBT Debt Disclosure [Text Block] Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued and outstanding as of March 31, 2026 and December 31, 2025 Preferred Stock, Value, Issued Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Interest Interest Payable Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Derek Meisner Plan 2, Shares Of Common Stock Received Upon Exercise Of Option Awards [Member] Derek Meisner Plan 2, Shares Of Common Stock Received Upon Exercise Of Option Awards All Executive Categories All Executive Categories [Member] Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Common stock, $0.0001 par value; 300,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 72,227,580 and 60,575,369 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Expected volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Share-Based Payment Arrangement, Tranche Two Share-Based Payment Arrangement, Tranche Two [Member] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Weighted-average shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Segment Information Segment Reporting, Policy [Policy Text Block] Commitments and contingencies (Note 10) Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Maximum number of patients per arm in trial Maximum Number Of Patients Per Arm In Trial Maximum Number Of Patients Per Arm In Trial Entity Small Business Entity Small Business Stock issuance offering costs Payments of Stock Issuance Costs Development Development [Member] Development 2024 Registration Statement 2024 Registration Statement [Member] 2024 Registration Statement [Member] Marketable securities Marketable Securities [Abstract] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Document Transition Report Document Transition Report Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Underlying Securities Award Underlying Securities Amount Debt securities, available-for-sale, unrealized loss position period (in months) Debt Securities, Available-for-Sale, Unrealized Loss Position Period Debt Securities, Available-for-Sale, Unrealized Loss Position Period Equity Component [Domain] Equity Component [Domain] Sale of stock, maximum authorized amount Sale of Stock, Maximum Authorized Amount Sale of Stock, Maximum Authorized Amount Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Accretion of debt discount Amortization of Debt Discount (Premium) Accrued clinical trial expenses Accrued Clinical Trial Expenses, Current Accrued Clinical Trial Expenses, Current 2021 Equity Incentive Plan 2021 Equity Incentive Plan [Member] 2021 Equity Incentive Plan Document Type Document Type Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Total Debt Securities, Available-for-Sale, Unrealized Loss Position [Abstract] Name Outstanding Recovery, Individual Name Marketable Securities [Table] Marketable Securities [Table] Additional paid-in capital Additional Paid in Capital Product and Service [Axis] Product and Service [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Derek Meisner Plan 2, Shares Of Common Stock Received Upon Vesting Of RSU Awards [Member] Derek Meisner Plan 2, Shares Of Common Stock Received Upon Vesting Of RSU Awards Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] All Individuals All Individuals [Member] Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Name Forgone Recovery, Individual Name Contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Outstanding stock maximum (as percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Minimum required payment (more than) Debt Instrument, Minimum Required Payment Debt Instrument, Minimum Required Payment Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Intrinsic value of stock options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Repurchase of common shares to pay employee withholding taxes Payment, Tax Withholding, Share-Based Payment Arrangement 2013 Equity Incentive Plan 2013 Equity Incentive Plan [Member] 2013 Equity Incentive Plan Private Placement Private Placement [Member] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Marketable securities, short-term Marketable Securities, Current Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Current liabilities Liabilities, Current [Abstract] Weighted Average Remaining Contractual Life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Total operating expenses Operating Expenses Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Reportable Segment Reportable Segment [Member] Reportable Segment Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Net loss per common share, diluted (in dollars per share) Earnings Per Share, Diluted Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Title of 12(b) Security Title of 12(b) Security Vested and exercisable, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Supplemental disclosure of noncash financing activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Prepaid insurance Prepaid Insurance Maximum threshold common stock issuable on exercise of incentive stock options (in shares) Share-Based Payment Arrangement, Maximum Threshold Common Stock Issuable on Exercise of Incentive Stock Options Share-Based Payment Arrangement, Maximum Threshold Common Stock Issuable on Exercise of Incentive Stock Options Sale of stock, number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Total other income Other income, net Nonoperating Income (Expense) Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Available-for-sale securities, short-term Debt Securities, Available-for-Sale, Current Embedded Derivative Financial Instruments Embedded Derivative Financial Instruments [Member] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Cash paid for income taxes Income Taxes Paid, Net Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Award Timing Disclosures [Line Items] Principal value of Term Loan, including Final Payment of $1,635 Total principal payments due for Term Loan Long-Term Debt, Gross Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price STOCKHOLDERS’ EQUITY Equity [Text Block] Net loss Net loss Net loss Segment net loss Net Income (Loss) Attributable to Parent Schedule of Unrealized Losses Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Expiration Date Trading Arrangement Expiration Date Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Property and equipment, net Property, Plant and Equipment, Net Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Adoption Date Trading Arrangement Adoption Date Vested and exercisable (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Entity Current Reporting Status Entity Current Reporting Status Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Loss from operations Operating Income (Loss) Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Change in fair value of embedded derivatives Change in fair value of embedded derivatives Embedded Derivative, Gain (Loss) on Embedded Derivative, Net Vesting of restricted stock units, net of shares withheld for taxes (in shares) Common stock issued in settlement of vested RSUs (in shares) Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Financial Instrument [Axis] Financial Instrument [Axis] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Unrealized Losses Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Registration Statement Registration Statement [Member] Registration Statement Class of Stock [Axis] Class of Stock [Axis] Current Fiscal Year End Date Current Fiscal Year End Date Royalty percentage Collaborative Arrangement, Royalty Percentage Collaborative Arrangement, Royalty Percentage Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Unrealized Losses Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Award Date, One Award Date, One [Member] Award Date, One Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Shares available for future grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Statement [Table] Statement [Table] Other expense, net Other Nonoperating Income (Expense) Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Weighted average grant date fair value of options granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Debt, long-term Debt Instrument, Fair Value Disclosure [Abstract] Unrealized Losses Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Proceeds from maturities and sales of marketable securities Proceeds from Sale and Maturity of Marketable Securities Cash and cash equivalents Cash and Cash Equivalents [Abstract] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Sale of stock, price per share (in dollars per share) Sale of Stock, Price Per Share Number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Other Commitments [Table] Other Commitments [Table] Termination Date Trading Arrangement Termination Date Net cash provided by (used in) financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Share-Based Payment Arrangement, Tranche Three Share-Based Payment Arrangement, Tranche Three [Member] Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Weighted-average shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Warrant, fair value Warrants and Rights Outstanding Segment Reporting [Abstract] Term Loan, Second Tranche Term Loan, Second Tranche [Member] Term Loan, Second Tranche Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Debt Disclosure [Abstract] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Other income (expense) Nonoperating Income (Expense) [Abstract] Entity Tax Identification Number Entity Tax Identification Number Debt securities, available-for-sale, realized gains Debt Securities, Available-for-Sale, Realized Gain (Loss) Unamortized debt discount Debt Instrument, Unamortized Discount Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Debt securities, available-for-sale, unrealized loss Debt Securities, Available-for-Sale, Unrealized Loss Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares issued (in shares) Common Stock, Shares, Issued Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Use of Estimates Use of Estimates, Policy [Policy Text Block] Shares issuable upon conversion election for term loan facility Convertible Debt Securities [Member] Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Change in fair value of embedded derivatives Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost [Abstract] Number of patients enrolled in trail Number Of Patients Enrolled In Trial Number Of Patients Enrolled In Trial Supplemental Financial Information [Abstract] Supplemental Financial Information [Abstract] Supplemental financial information [Abstract]. Year ended December 31, 2026 Long-Term Debt, Maturity, Remainder of Fiscal Year Total liabilities Liabilities Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Principle borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Operating expenses Operating expenses Operating Expenses [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] At The Market Offering At The Market Offering [Member] At The Market Offering Debt Instrument Redemption [Table] Debt Instrument Redemption [Table] Aggregate Intrinsic Value (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Intrinsic Value [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Intrinsic Value Private placement issuance of common stock, net of offering costs Stock Issued During Period, Value, New Issues Statement [Line Items] Statement [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalent Vesting of restricted stock units, net of shares withheld for taxes Restricted Stock, Value, Shares Issued Net of Tax Withholdings Counterparty Name [Axis] Counterparty Name [Axis] Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Common Stock Common Stock [Member] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Compensation and other employee liabilities Employee-related Liabilities Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Term Loan Term Loan [Member] Term Loan Non-NEOs Non-NEOs [Member] Corporate debt securities Corporate Debt Securities [Member] Term Loan, First Tranche Term Loan, First Tranche [Member] Term Loan, First Tranche